We bring you the latest news from the healthcare about the health care in the United Kingdom.

zaterdag 7 april 2018

The Lancet: [Comment] Combining top-ranked immunotherapeutics in lung cancer

[Comment] Combining top-ranked immunotherapeutics in lung cancer
Immunotherapy is becoming widely used in the treatment of non-small-cell lung cancer (NSCLC) in light of its impressive results in both first-line and second-line settings.1 However, doctors need to accept that not all patients can be treated with this approach and much still remains to be done to improve outcomes for patients with this lethal disease. Combining new immunotherapeutic agents with existing treatments such as chemotherapy or tyrosine kinases inhibitors can have both good and bad consequences.
Read more

[Articles] ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
ALT-803 in combination with nivolumab can be safely administered in an outpatient setting. The promising clinical activity observed with the addition of ALT-803 to the regimen of patients with PD-1 monoclonal antibody relapsed and refractory disease shows evidence of anti-tumour activity for a new class of agents in NSCLC.
Read more

[News] Lawsuit filed against FDA for not reviewing e-cigarettes
The American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and five individual paediatricians are suing the US Food and Drug Administration (FDA) over their decision in July, 2017, to delay reviewing electronic cigarettes (e-cigarettes) and e-cigars.
Read more

[News] Short vs long course adjuvant chemotherapy for colon cancer
The results of the International Duration Evaluation of Adjuvant Therapy (IDEA) collaboration project did not confirm the non-inferiority of 3 months of adjuvant therapy compared with the standard 6 months in patients with stage 3 colon cancer.
Read more

[News] Health care for cancer survivors in the USA
Despite a substantial increase in insurance coverage, cancer survivors in the USA face difficulties in health-care access and affordability compared with adults without cancer; however, new research suggests that after the implementation of the Affordable Care Act, these difficulties among cancer survivors showed a decreasing trend.
Read more